Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
- Substances:BortezomibDexamethasone+4
Spain- Participants:0–17 years
- Substances:Bortezomib
- Sponsor:Charite Universitaetsmedizin Berlin KöR
Rare diseases
Investigational molecules
Locations
Back to Spain1 777 clinical trials in Valencia, Spain across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
SpainStudy to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies
SpainStudy on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer
SpainStudy of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer
SpainStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainStudy Comparing Non-Invasive Ventilation and High Flow Oxygen Therapy for Patients at Risk of Breathing Support Failure After Ventilator Removal
SpainStudy on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors
SpainLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
SpainStudy of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer
SpainStudy of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations
SpainStudy on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focused on Mantle Cell Lymphoma treatments and Immune Thrombocytopenia, evaluating novel therapeutic combinations and investigating new treatment approaches.
Studies aim to improve treatment outcomes and provide alternative therapeutic options for patients.
Comprehensive studies addressing Respiratory Syncytial Virus, ARDS, and COPD, with focus on innovative treatments and preventive measures.
Research emphasizes both therapeutic interventions and preventive strategies for respiratory diseases.
Advanced research into acute ischemic stroke treatments and outcomes, investigating novel therapeutic approaches for better patient recovery.
Focus on improving functional outcomes and reducing complications in stroke patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.